Acute Kidney Injury in Coronavirus Disease 2019 Infected Patients: A Meta-Analytic Study
- 2 July 2020
- journal article
- research article
- Published by S. Karger AG in Blood Purification
- Vol. 50 (1) , 35-41
Abstract
Introduction: In clinical reports on coronavirus disease 2019 (COVID-19), the incidence of acute kidney injury (AKI) is extremely variable, although AKI is described as an independent risk factor for mortality. A meta-analysis was performed to clarify the incidence and the impact of COVID-19-related AKI on mortality. Methods: All trials reporting the incidence of AKI in COVID-19 patients were searched using MEDLINE, the Cochrane Library, and EMBASE databases (last update April 26, 2020). Results: Ten trials with a sample of 5,166 patients were included. AKI occurred in 947 out of 5,166 (18.3%) patients. AKI incidence was higher in severe cases: 62/305 severe patients developed AKI (20%) versus 27/1,268 nonsevere patients (2%) (p = 0.00001). AKI occurred in 475 out of 915 (52%) deceased patients versus 183 out of 2,678 (7%) survivors (p = 0.00001). Continuous renal replacement therapy was significantly more frequent in severe cases and in dead patients. Conclusion: A significant increase in mortality rate was observed in COVID patients who developed AKI, and AKI incidence was also higher in severe cases. Any supportive strategies to protect kidney could represent valuable intervention to reduce mortality in severe COVID-19 patients.Keywords
This publication has 25 references indexed in Scilit:
- Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, ChinaJournal of Infection, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaNew England Journal of Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Factors associated with acute kidney injury in acute respiratory distress syndromeAnnals of Intensive Care, 2019
- Lung–Kidney Cross-Talk in the Critically Ill PatientAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Coronaviruses — drug discovery and therapeutic optionsNature Reviews Drug Discovery, 2016
- Into the Eye of the Cytokine StormMicrobiology and Molecular Biology Reviews, 2012
- Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting EnzymeJournal of the American Society of Nephrology, 2006
- Acute renal impairment in coronavirus-associated severe acute respiratory syndromeKidney International, 2005